| First Author | Choi Y | Year | 2023 |
| Journal | Int J Mol Sci | Volume | 24 |
| Issue | 11 | PubMed ID | 37298502 |
| Mgi Jnum | J:348455 | Mgi Id | MGI:7490836 |
| Doi | 10.3390/ijms24119552 | Citation | Choi Y, et al. (2023) Capacitive Electrode-Based Electric Field Treatments on Redox-Toxic Iron Deposits in Transgenic AD Mouse Models: The Electroceutical Targeting of Alzheimer's Disease Feasibility Study. Int J Mol Sci 24(11) |
| abstractText | Iron accumulation in the brain accelerates Alzheimer's disease progression. To cure iron toxicity, we assessed the therapeutic effects of noncontact transcranial electric field stimulation to the brain on toxic iron deposits in either the Abeta fibril structure or the Abeta plaque in a mouse model of Alzheimer's disease (AD) as a pilot study. A capacitive electrode-based alternating electric field (AEF) was applied to a suspension of magnetite (Fe(3)O(4)) to measure field-sensitized reactive oxygen species (ROS) generation. The increase in ROS generation compared to the untreated control was both exposure-time and AEF-frequency dependent. The frequency-specific exposure of AEF to 0.7-1.4 V/cm on a magnetite-bound Abeta-fibril or a transgenic Alzheimer's disease (AD) mouse model revealed the degradation of the Abeta fibril or the removal of the Abeta-plaque burden and ferrous magnetite compared to the untreated control. The results of the behavioral tests show an improvement in impaired cognitive function following AEF treatment on the AD mouse model. Tissue clearing and 3D-imaging analysis revealed no induced damage to the neuronal structures of normal brain tissue following AEF treatment. In conclusion, our results suggest that the effective degradation of magnetite-bound amyloid fibrils or plaques in the AD brain by the electro-Fenton effect from electric field-sensitized magnetite offers a potential electroceutical treatment option for AD. |
